Showing 1 - 9 results of 9 for search 'Michael J Brownstein', query time: 0.03s
Refine Results
-
1
-
2
-
3
-
4
Successful Treatment of <i>Staphylococcus aureus</i> Prosthetic Joint Infection with Bacteriophage Therapy by Claudia Ramirez-Sanchez, Francis Gonzales, Maureen Buckley, Biswajit Biswas, Matthew Henry, Michael V. Deschenes, Bri’Anna Horne, Joseph Fackler, Michael J. Brownstein, Robert T. Schooley, Saima Aslam
Published 2021-06-01
Article -
5
Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent by Syed Faizan Mehdi, Suma Pusapati, Muhammad Saad Anwar, Durga Lohana, Parkash Kumar, Savitri Aninditha Nandula, Fatima Kausar Nawaz, Kevin Tracey, Huan Yang, Derek LeRoith, Michael J. Brownstein, Jesse Roth
Published 2023-05-01
Article -
6
Oxytocin and Related Peptide Hormones: Candidate Anti-Inflammatory Therapy in Early Stages of Sepsis by Syed Faizan Mehdi, Suma Pusapati, Raja Ram Khenhrani, Muhammad Saad Farooqi, Sobia Sarwar, Ahmad Alnasarat, Nimisha Mathur, Christine Noel Metz, Derek LeRoith, Kevin J. Tracey, Huan Yang, Michael J. Brownstein, Jesse Roth
Published 2022-04-01
Article -
7
Bacterial lysis, autophagy and innate immune responses during adjunctive phage therapy in a child by Ameneh Khatami, Ruby C Y Lin, Aleksandra Petrovic‐Fabijan, Sivan Alkalay‐Oren, Sulaiman Almuzam, Philip N Britton, Michael J Brownstein, Quang Dao, Joe Fackler, Ronen Hazan, Bri’Anna Horne, Ran Nir‐Paz, Jonathan R Iredell
Published 2021-09-01
Article -
8
A proof-of-concept randomized crossover clinical trial of a first-in-class vasopressin 1a receptor antagonist for PTSD: Design, methods, and recruitment by JoAnn Difede, Andrew A. McAleavey, Mariel Emrich, Adina Jick, Annell Ovalles, Katarzyna Wyka, Lisa Spielman, Megan Olden, Melissa Peskin, Colleen Becket-Davenport, Amy Rubenstein, Michael J. Brownstein, Eve Damiano, Debra Itzkowitz, Shi-fang Lu, Nancy J. Needell, James H. Kocsis, Janna S. Gordon-Elliott, Neal G. Simon
Published 2023-06-01
Article -
9
Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington’s Disease Patients—A Randomized Phase 2 Clinical Trial by Michael J. Brownstein, Neal G. Simon, Jeffrey D. Long, Jon Yankey, Hilda T. Maibach, Merit Cudkowicz, Christopher Coffey, Robin A. Conwit, Codrin Lungu, Karen E. Anderson, Steven M. Hersch, Dixie J. Ecklund, Eve M. Damiano, Debra E. Itzkowitz, Shifang Lu, Marianne K. Chase, Jeremy M. Shefner, Andrew McGarry, Brenda Thornell, Catherine Gladden, Michele Costigan, Padraig O'Suilleabhain, Frederick J. Marshall, Amy M. Chesire, Paul Deritis, Jamie L. Adams, Peter Hedera, Kelly Lowen, H. Diana Rosas, Amie L. Hiller, Joseph Quinn, Kellie Keith, Andrew P. Duker, Christina Gruenwald, Angela Molloy, Cara Jacob, Stewart Factor, Elaine Sperin, Danny Bega, Zsazsa R. Brown, Lauren C. Seeberger, Victor W. Sung, Melanie Benge, Sandra K. Kostyk, Allison M. Daley, Susan Perlman, Valerie Suski, Patricia Conlon, Matthew J. Barrett, Stephanie Lowenhaupt, Mark Quigg, Joel S. Perlmutter, Brenton A. Wright, Elaine Most, Guy J. Schwartz, Jessica Lamb, Rosalind S. Chuang, Carlos Singer, Karen Marder, Joyce A. Moran, John R. Singleton, Meghan Zorn, Paola V. Wall, Richard M. Dubinsky, Carolyn Gray, Carolyn Drazinic
Published 2020-11-01
Article